Strides Pharma Global receives AUD 94 mn for sale of Australia's operations
The balance of AUD 94 Million was a deferred consideration backed by a secured interest-bearing instrument
The balance of AUD 94 Million was a deferred consideration backed by a secured interest-bearing instrument
The expansion in Indore is well-aligned with Lupin Diagnostics’ commitment to improving access to high-quality, reliable, and advanced testing centres and home collection facilities at an affordable price
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
The project will generate and supply green energy to fulfill about 50% present consumption of the company
The scheme is subject to statutory and regulatory approvals as may be necessary.
He has published more than 100 research papers in several prestigious national and international journals
Indira IVF integrates diagnostics services with a special focus on women & child care to increase accessibility for patients
Allam was serving recently as the CEO at Public Investment Fund
Subscribe To Our Newsletter & Stay Updated